Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Circulating folate levels and colorectal adenoma: a case-control study and a meta-analysis.

Park YM, Youn J, Cho CH, Kim SH, Lee JE.

Nutr Res Pract. 2017 Oct;11(5):419-429. doi: 10.4162/nrp.2017.11.5.419. Epub 2017 Sep 7.

2.

High-Quality Diets Associate With Reduced Risk of Colorectal Cancer: Analyses of Diet Quality Indexes in the Multiethnic Cohort.

Park SY, Boushey CJ, Wilkens LR, Haiman CA, Le Marchand L.

Gastroenterology. 2017 Aug;153(2):386-394.e2. doi: 10.1053/j.gastro.2017.04.004. Epub 2017 Apr 17.

PMID:
28428143
3.

Untangling the role of one-carbon metabolism in colorectal cancer risk: a comprehensive Bayesian network analysis.

Myte R, Gylling B, Häggström J, Schneede J, Magne Ueland P, Hallmans G, Johansson I, Palmqvist R, Van Guelpen B.

Sci Rep. 2017 Feb 24;7:43434. doi: 10.1038/srep43434.

4.

Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China.

Ren J, Murphy G, Fan J, Dawsey SM, Taylor PR, Selhub J, Qiao Y, Abnet CC.

Sci Rep. 2016 Oct 17;6:35281. doi: 10.1038/srep35281.

5.

Comparative effectiveness of chemopreventive interventions for colorectal cancer: protocol for a systematic review and network meta-analysis of randomised controlled trials.

Veettil SK, Saokaew S, Lim KG, Ching SM, Phisalprapa P, Chaiyakunapruk N.

J Gastrointest Oncol. 2016 Aug;7(4):595-602. doi: 10.21037/jgo.2016.04.02.

6.

Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers.

Miranti EH, Freedman ND, Weinstein SJ, Abnet CC, Selhub J, Murphy G, Diaw L, Männistö S, Taylor PR, Albanes D, Stolzenberg-Solomon RZ.

Am J Clin Nutr. 2016 Sep;104(3):686-93. doi: 10.3945/ajcn.115.125799. Epub 2016 Aug 17.

7.

Genetic variants in 3'-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans.

Jeon YJ, Kim JW, Park HM, Kim JO, Jang HG, Oh J, Hwang SG, Kwon SW, Oh D, Kim NK.

Sci Rep. 2015 Jun 5;5:11006. doi: 10.1038/srep11006.

8.

Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals.

Zhang D, Wen X, Wu W, Guo Y, Cui W.

PLoS One. 2015 May 18;10(5):e0123423. doi: 10.1371/journal.pone.0123423. eCollection 2015.

9.

Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.

Neuhouser ML, Cheng TY, Beresford SA, Brown E, Song X, Miller JW, Zheng Y, Thomson CA, Shikany JM, Vitolins MZ, Rohan T, Green R, Ulrich CM.

Int J Cancer. 2015 Aug 15;137(4):930-9. doi: 10.1002/ijc.29453. Epub 2015 Feb 24.

10.

Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.

Keshteli AH, Baracos VE, Madsen KL.

World J Gastroenterol. 2015 Jan 28;21(4):1081-90. doi: 10.3748/wjg.v21.i4.1081. Review.

11.

Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex.

Shrubsole MJ, Wagner C, Zhu X, Hou L, Loukachevitch LV, Ness RM, Zheng W.

Am J Cancer Res. 2014 Dec 15;5(1):458-65. eCollection 2015.

12.

Fecal metabolomics: assay performance and association with colorectal cancer.

Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R.

Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.

13.

Plasma folate concentrations and colorectal cancer risk: a case-control study nested within the Shanghai Men's Health Study.

Takata Y, Shrubsole MJ, Li H, Cai Q, Gao J, Wagner C, Wu J, Zheng W, Xiang YB, Shu XO.

Int J Cancer. 2014 Nov 1;135(9):2191-8. doi: 10.1002/ijc.28871. Epub 2014 Apr 11.

14.

Intraindividual variation in one-carbon metabolism plasma biomarkers.

Cope EL, Shrubsole MJ, Cohen SS, Cai Q, Wu J, Ueland PM, Midttun Ø, Sonderman JS, Blot WJ, Signorello LB.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1894-9. doi: 10.1158/1055-9965.EPI-13-0420. Epub 2013 Aug 15.

15.

Vitamin B6 and colorectal cancer: current evidence and future directions.

Zhang XH, Ma J, Smith-Warner SA, Lee JE, Giovannucci E.

World J Gastroenterol. 2013 Feb 21;19(7):1005-10. doi: 10.3748/wjg.v19.i7.1005. Review.

16.

Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort.

Miller JW, Beresford SA, Neuhouser ML, Cheng TY, Song X, Brown EC, Zheng Y, Rodriguez B, Green R, Ulrich CM.

Am J Clin Nutr. 2013 Apr;97(4):827-34. doi: 10.3945/ajcn.112.049932. Epub 2013 Feb 20.

17.

B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort.

Zschäbitz S, Cheng TY, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM.

Am J Clin Nutr. 2013 Feb;97(2):332-43. doi: 10.3945/ajcn.112.034736. Epub 2012 Dec 19.

18.

Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies.

Lee JE, Wei EK, Fuchs CS, Hunter DJ, Lee IM, Selhub J, Stampfer MJ, Willett WC, Ma J, Giovannucci E.

Cancer Causes Control. 2012 Apr;23(4):537-45. doi: 10.1007/s10552-012-9911-3. Epub 2012 Feb 26.

19.

Association of plasma vitamin B6 with risk of colorectal adenoma in a multiethnic case-control study.

Le Marchand L, Wang H, Selhub J, Vogt TM, Yokochi L, Decker R.

Cancer Causes Control. 2011 Jun;22(6):929-36. doi: 10.1007/s10552-011-9759-y. Epub 2011 Mar 25.

20.

Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.

Figueiredo JC, Mott LA, Giovannucci E, Wu K, Cole B, Grainge MJ, Logan RF, Baron JA.

Int J Cancer. 2011 Jul 1;129(1):192-203. doi: 10.1002/ijc.25872. Epub 2011 Apr 1.

Supplemental Content

Support Center